Provexis – The Company

Provexis Limited was founded in 1999 to launch Fruitflow® – the patented natural extract from tomatoes which has been shown in human trials to be anti-thrombotic. Fruitflow® was discovered at the Rowett Research Institute by Professor Asim Duttaroy.

Specialising in functional food and dietary supplements, at Provexis we have a clear focus to deliver products with high quality scientific intellectual property from the laboratory through to successful launch.

Fruitflow® was launched in Europe in November 2010 at the Health Ingredients Europe Conference, where it was awarded ‘Most Innovative Health Ingredient’ and won the best innovation in the ‘Heart Health’ category.

The US trade launch was at the Natural Products Expo West in 2011. In 2012 Fruitflow® was named one of the most innovative products of the year at the Food Ingredients South America trade show.

Provexis plc was listed on the Alternative Investment Market (AIM) in 2005 with the stock symbol PXS.

ABOUT US

Scientific Advisory Board

Professor Asim K Duttaroy

Professor Duttaroy discovered Fruitflow® and is a globally recognised expert in the field of nutrition studies. Professor Duttaroy is currently Group Leader of Chronic Disease at the University of Oslo’s Faculty of Medicine, and also the editor in chief of the international peer reviewed journal Food & Nutrition Research.

Dr Niamh O’Kennedy BSc MSc PhD

Dr O’Kennedy is a research chemist, specialising in the field of natural products chemistry, who has been working with Provexis since 2000. Niamh’s experience in isolating and characterising plant-derived compounds and understanding the roles these play in complex biological systems has been pivotal in the development of Provexis’ lead product, Fruitflow®, and the health claim for Fruitflow® which was adopted by the European Food Safety Authority (‘EFSA’).

ABOUT US

Board of Directors

Dawson Buck

Non-executive Chairman

Dawson has over twenty years’ senior international experience within the electronic security, property, retail and IT industries. Dawson was a founder and the CEO of Automated Loss Prevention Ltd, which he led from its inception to its sale to the Sensormatic Electronic Corporation Inc. in 1992. Until 2005 Dawson was Deputy Chief Executive of ANGLE plc.

Ian Ford, BA (Hons) ACA

CEO and CFO

Ian is a Chartered Accountant who trained with PwC and its predecessor firms in London. Ian has over 25 years’ post qualification experience, with more than 20 years in senior financial roles with UK and US listed growth companies, to include Rubicon Group plc and SITEL Europe plc, the latter as Group Finance Director. Ian played key roles in the rapid growth of these businesses, including extensive merger and acquisition activity. Ian joined the Company as Finance Director in 2007 and he has been very closely involved with the Company’s relationships and contracts with DSM, By-Health and the Company’s investors over that time.

Frédéric Boned

Non-executive Director

Frédéric is EMEA Vice President of DSM’s Human Nutrition & Health business, a part of DSM Nutritional Products. Frédéric has previously held a variety of senior roles in DSM’s Personal Care & Aroma Ingredients business including Director of Personal Care EMEA and Senior Director of Global Marketing and Innovation. Prior to DSM, Frédéric held several sales and marketing positions for over ten years at Givaudan. Frédéric has a chemical engineering degree from the Engineering School in Geneva, and an EMBA from the Business School of Lausanne.

Dr Niamh O’Kennedy BSc MSc PhD

Chief Scientific Officer

Dr O’Kennedy is a research chemist, specialising in the field of natural products chemistry, who has been working with Provexis since 2000. Niamh’s experience in isolating and characterising plant-derived compounds and understanding the roles these play in complex biological systems has been pivotal in the development of Provexis’ lead product, Fruitflow®, and the health claim for Fruitflow® which was adopted by the European Food Safety Authority (‘EFSA’).